These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8369512)

  • 61. Incremental yield in sputum smear positivity by examining a second early morning sputum specimen in follow-up patients on DOTS: 7 year analysis of RNTCP laboratory register.
    Nataraj G; Kanade S; Parikh R; Khatri V; Mehta P; Athavale A; Arun B
    Indian J Tuberc; 2011 Apr; 58(2):60-5. PubMed ID: 21644391
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low level of compliance with tuberculosis treatment in children: monitoring by urine tests.
    Palanduz A; Gültekin D; Erdem E; Kayaalp N
    Ann Trop Paediatr; 2003 Mar; 23(1):47-50. PubMed ID: 12648324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Controlled trial of ciprofloxacin in short-term chemotherapy for pulmonary tuberculosis.
    Mohanty KC; Dhamgaye TM
    Chest; 1993 Oct; 104(4):1194-8. PubMed ID: 8404191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Short-course therapy of pulmonary tuberculosis: doctor's compliance.
    Rothe TB; Karrer W
    Tuber Lung Dis; 1996 Feb; 77(1):93-7. PubMed ID: 8733422
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tuberculosis control programme in Beijing.
    Zhang LX; Kan GQ
    Tuber Lung Dis; 1992 Jun; 73(3):162-6. PubMed ID: 1421349
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A successful supervised outpatient short-course tuberculosis treatment program in an open refugee camp on the Thai-Cambodian border.
    Miles SH; Maat RB
    Am Rev Respir Dis; 1984 Nov; 130(5):827-30. PubMed ID: 6497162
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pulmonary tuberculosis in Kumasi, Ghana: presentation, drug resistance, molecular epidemiology and outcome of treatment.
    Lawn SD; Frimpong EH; Al-Ghusein H; Acheampong JW; Uttley AH; Butcher PD; Griffin GE
    West Afr J Med; 2001; 20(2):92-7. PubMed ID: 11768026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Can serial qualitative polymerase chain reaction monitoring predict outcome of pulmonary tuberculosis treatment?
    Chierakul N; Chaiprasert A; Tingtoy N; Arjratanakul W; Pattanakitsakul SN
    Respirology; 2001 Dec; 6(4):305-9. PubMed ID: 11844121
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tuberculosis in an Indochinese refugee camp: epidemiology, management and therapeutic results.
    Rieder HL
    Tubercle; 1985 Sep; 66(3):179-86. PubMed ID: 4049529
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effectiveness of isoniazid inhalation in patients with endobronchial tuberculosis].
    Miki K; Yokota S; Hiraga T; Yamaguchi T; Nakagawa M; Maekura R; Ito M; Ogura T
    Nihon Kokyuki Gakkai Zasshi; 1999 Jan; 37(1):31-5. PubMed ID: 10087873
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A service programme with a 6-month intensive chemotherapy regimen in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong.
    Tubercle; 1983 Dec; 64(4):265-74. PubMed ID: 6659074
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
    Banks J; Jenkins PA; Smith AP
    Tubercle; 1985 Sep; 66(3):197-203. PubMed ID: 4049531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of nonlinear mixed-effects analysis for improved precision of early pharmacodynamic measures in tuberculosis treatment.
    Davies GR; Brindle R; Khoo SH; Aarons LJ
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3154-6. PubMed ID: 16940116
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The impact of nutritional state on the duration of sputum positivity of Mycobacterium tuberculosis.
    Hatsuda K; Takeuchi M; Ogata K; Sasaki Y; Kagawa T; Nakatsuji H; Ibaraki M; Sakaguchi M; Kurata M; Hayashi S
    Int J Tuberc Lung Dis; 2015 Nov; 19(11):1369-75. PubMed ID: 26467590
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Morbidity and mortality at five years after initiating Category I treatment among patients with new sputum smear positive pulmonary tuberculosis.
    Lisha PV; James PT; Ravindran C
    Indian J Tuberc; 2012 Apr; 59(2):83-91. PubMed ID: 22838205
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Attendance versus compliance with tuberculosis treatment in an occupational setting--a pilot study.
    Mqoqi NP; Churchyard GA; Kleinschmidt I; Williams B
    S Afr Med J; 1997 Nov; 87(11):1517-21. PubMed ID: 9472274
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis.
    Tubercle; 1981 Sep; 62(3):155-67. PubMed ID: 7032018
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Smoking prolongs the infectivity of patients with tuberculosis.
    Siddiqui UA; O'Toole M; Kabir Z; Qureshi S; Gibbons N; Kane M; Keane J
    Ir Med J; 2010 Oct; 103(9):278-80. PubMed ID: 21186753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Present-day aspects (diagnosis, clinical course and treatment) of acute progressive pulmonary tuberculosis].
    Mishin VIu
    Vestn Ross Akad Med Nauk; 2000; (12):21-5. PubMed ID: 11202638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.
    Sirgel FA; Botha FJ; Parkin DP; Van de Wal BW; Schall R; Donald PR; Mitchison DA
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):901-5. PubMed ID: 9310011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.